Crinetics Pharmaceuticals Inc (CRNX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: CRNX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-03-21	2025-03-19	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	291 -0.3% 34.83 USD 10,136	291 -0.3%	34.83	USD 10,136
2025-03-21	2025-03-19	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	5,479 -4.8% 34.17 USD 187,217	5,479 -4.8%	34.17	USD 187,217
2025-03-21	2025-03-19	PS Planned sale	Struthers Richard Scott President & CEO Executive Director	875 -0.3% 34.83 USD 30,476	875 -0.3%	34.83	USD 30,476
2025-03-21	2025-03-19	PS Planned sale	Struthers Richard Scott President & CEO Executive Director	16,463 -4.8% 34.17 USD 562,541	16,463 -4.8%	34.17	USD 562,541
2025-03-21	2025-03-19	PS Planned sale	Knight Jeff E. Chief Operating Officer Officer	361 -0.4% 34.83 USD 12,574	361 -0.4%	34.83	USD 12,574
2025-03-21	2025-03-19	PS Planned sale	Knight Jeff E. Chief Operating Officer Officer	6,801 -7.2% 34.17 USD 232,390	6,801 -7.2%	34.17	USD 232,390
2025-03-21	2025-03-19	PS Planned sale	Pizzuti Dana Chief Med and Dev Officer Officer	127 -0.2% 34.83 USD 4,423	127 -0.2%	34.83	USD 4,423
2025-03-21	2025-03-19	PS Planned sale	Pizzuti Dana Chief Med and Dev Officer Officer	2,388 -3.2% 34.17 USD 81,598	2,388 -3.2%	34.17	USD 81,598
2025-02-05	2025-02-03	PS Planned sale	Pizzuti Dana Chief Med and Dev Officer Officer	5,000 -13.6% 39.07 USD 195,350	5,000 -13.6%	39.07	USD 195,350
2025-01-07	2025-01-03	PS Planned sale	Pizzuti Dana Chief Med and Dev Officer Officer	15,000 -33.9% 52.09 USD 781,350	15,000 -33.9%	52.09	USD 781,350
2024-12-04	2024-12-02	PS Planned sale	Struthers Richard Scott President & CEO Executive Director	10,000 -9.1% 57.57 USD 575,700	10,000 -9.1%	57.57	USD 575,700
2024-11-26	2024-11-22	PS Planned sale	Knight Jeff E. Chief Operating Officer Officer	501 -1.0% 56.52 USD 28,317	501 -1.0%	56.52	USD 28,317
2024-10-07	2024-10-03	PS Planned sale	Pizzuti Dana Chief Med and Dev Officer Officer	14,375 -33.5% 54.63 USD 785,306	14,375 -33.5%	54.63	USD 785,306
2024-09-30	2024-09-26	PS Planned sale	Wilson Marc CFO Officer	25,000 -18.4% 51.11 USD 1,277,750	25,000 -18.4%	51.11	USD 1,277,750
2024-09-12	2024-09-10	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	1,035 -1.5% 51.50 USD 53,303	1,035 -1.5%	51.50	USD 53,303
2024-08-28	2024-08-26	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -4.1% 53.19 USD 159,570	3,000 -4.1%	53.19	USD 159,570
2024-08-14	2024-08-12	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -4.0% 47.68 USD 143,040	3,000 -4.0%	47.68	USD 143,040
2024-07-26	2024-07-25	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.8% 53.43 USD 160,290	3,000 -3.8%	53.43	USD 160,290
2024-07-26	2024-07-25	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.8% 53.43 USD 160,290	3,000 -3.8%	53.43	USD 160,290
2024-07-26	2024-07-25	PS Planned sale	Wilson Marc CFO Officer	19,056 -14.6% 53.88 USD 1,026,737	19,056 -14.6%	53.88	USD 1,026,737
2024-07-26	2024-07-25	PS Planned sale	Wilson Marc CFO Officer	19,056 -14.6% 53.88 USD 1,026,737	19,056 -14.6%	53.88	USD 1,026,737
2024-07-17	2024-07-15	PS Planned sale	Knight Jeff E. Chief Operating Officer Officer	27,000 -34.3% 55.00 USD 1,485,000	27,000 -34.3%	55.00	USD 1,485,000
2024-07-17	2024-07-15	PS Planned sale	Wilson Marc CFO Officer	25,000 -18.4% 55.00 USD 1,375,000	25,000 -18.4%	55.00	USD 1,375,000
2024-07-12	2024-07-10	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.7% 48.55 USD 145,650	3,000 -3.7%	48.55	USD 145,650
2024-07-09	2024-07-05	PS Planned sale	Hassard James Chief Commercial Officer Officer	15,000 -33.9% 44.08 USD 661,200	15,000 -33.9%	44.08	USD 661,200
2024-07-05	2024-07-03	PS Planned sale	Pizzuti Dana Chief Med and Dev Officer Officer	14,375 -33.5% 44.87 USD 645,006	14,375 -33.5%	44.87	USD 645,006
2024-07-02	2024-06-28	PS Planned sale	Wilson Marc CFO Officer	32,129 -22.4% 43.61 USD 1,401,146	32,129 -22.4%	43.61	USD 1,401,146
2024-06-28	2024-06-26	PS Planned sale	Knight Jeff E. Chief Operating Officer Officer	956 -1.8% 44.38 USD 42,427	956 -1.8%	44.38	USD 42,427
2024-06-26	2024-06-25	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.6% 45.37 USD 136,110	3,000 -3.6%	45.37	USD 136,110
2024-06-25	2024-06-24	S Sale	Pizzuti Dana Chief Med and Dev Officer Officer	9,500 -25.5% 45.73 USD 434,435	9,500 -25.5%	45.73	USD 434,435
2024-06-24	2024-06-21	PS Planned sale	Hassard James Chief Commercial Officer Officer	15,000 -33.9% 44.66 USD 669,900	15,000 -33.9%	44.66	USD 669,900
2024-06-11	2024-06-10	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.5% 43.86 USD 131,580	3,000 -3.5%	43.86	USD 131,580
2024-05-30	2024-05-28	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.3% 47.49 USD 142,470	3,000 -3.3%	47.49	USD 142,470
2024-05-14	2024-05-10	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.2% 49.43 USD 148,290	3,000 -3.2%	49.43	USD 148,290
2024-05-10	2024-05-08	PS Planned sale	Struthers Richard Scott President & CEO Executive Director	107,448 -29.4% 49.40 USD 5,307,931	107,448 -29.4%	49.40	USD 5,307,931
2024-05-10	2024-05-08	PS Planned sale	Struthers Richard Scott President & CEO Executive Director	107,448 -29.4% 49.40 USD 5,307,931	107,448 -29.4%	49.40	USD 5,307,931
2024-04-17	2024-04-15	PS Planned sale	Pizzuti Dana Chief Med and Dev Officer Officer	14,375 -34.1% 44.47 USD 639,256	14,375 -34.1%	44.47	USD 639,256
2024-04-08	2024-04-04	PS Planned sale	Struthers Richard Scott President & CEO Executive Director	40,951 -14.7% 49.17 USD 2,013,561	40,951 -14.7%	49.17	USD 2,013,561
2024-04-02	2024-03-28	S Sale	Okey Stephanie Non-Executive Director	17,500 -74.5% 46.38 USD 811,650	17,500 -74.5%	46.38	USD 811,650
2024-03-26	2024-03-22	S Sale	Knight Jeff E. Chief Operating Officer Officer	2,359 -4.3% 45.39 USD 107,075	2,359 -4.3%	45.39	USD 107,075
2024-03-26	2024-03-22	S Sale	Knight Jeff E. Chief Operating Officer Officer	30,000 -35.3% 44.22 USD 1,326,600	30,000 -35.3%	44.22	USD 1,326,600
2024-03-22	2024-03-20	S Sale	Pizzuti Dana Chief Med and Dev Officer Officer	714 -2.5% 43.69 USD 31,195	714 -2.5%	43.69	USD 31,195
2024-03-22	2024-03-20	S Sale	Pizzuti Dana Chief Med and Dev Officer Officer	10,000 -26.0% 43.28 USD 432,800	10,000 -26.0%	43.28	USD 432,800
2024-03-22	2024-03-20	S Sale	Pizzuti Dana Chief Med and Dev Officer Officer	4,375 -13.3% 45.89 USD 200,769	4,375 -13.3%	45.89	USD 200,769
2024-03-22	2024-03-20	PS Planned sale	Fust Matthew K Non-Executive Director	17,500 -48.6% 45.50 USD 796,250	17,500 -48.6%	45.50	USD 796,250
2024-03-22	2024-03-20	PS Planned sale	Fust Matthew K Non-Executive Director	17,500 -48.6% 43.58 USD 762,650	17,500 -48.6%	43.58	USD 762,650
2024-03-22	2024-03-20	PS Planned sale	Fust Matthew K Non-Executive Director	12,500 -40.3% 43.57 USD 544,625	12,500 -40.3%	43.57	USD 544,625
2024-03-22	2024-03-20	PS Planned sale	Fust Matthew K Non-Executive Director	12,500 -40.3% 43.57 USD 544,625	12,500 -40.3%	43.57	USD 544,625
2024-03-20	2024-03-19	PS Planned sale	Wilson Marc CFO Officer	6,942 -5.9% 42.91 USD 297,881	6,942 -5.9%	42.91	USD 297,881
2024-01-26	2024-01-25	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.9% 37.26 USD 111,780	3,000 -3.9%	37.26	USD 111,780
2024-01-12	2024-01-10	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.8% 37.65 USD 112,950	3,000 -3.8%	37.65	USD 112,950
2024-01-04	2024-01-03	PS Planned sale	Pizzuti Dana Chief Med and Dev Officer Officer	14,375 -70.9% 35.00 USD 503,125	14,375 -70.9%	35.00	USD 503,125
2024-01-04	2024-01-02	PS Planned sale	Wilson Marc CFO Officer	10,000 -9.4% 35.47 USD 354,700	10,000 -9.4%	35.47	USD 354,700
2023-12-27	2023-12-26	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.6% 35.89 USD 107,670	3,000 -3.6%	35.89	USD 107,670
2023-12-22	2023-12-21	S Sale	Pizzuti Dana Chief Med and Dev Officer Officer	9,583 -61.8% 34.57 USD 331,284	9,583 -61.8%	34.57	USD 331,284
2023-12-13	2023-12-11	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.5% 32.87 USD 98,610	3,000 -3.5%	32.87	USD 98,610
2023-11-29	2023-11-27	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,000 -3.4% 31.84 USD 95,520	3,000 -3.4%	31.84	USD 95,520
2023-11-06	2023-11-03	S Sale	Struthers Richard Scott President & CEO Executive Director	199,082 -59.5% 30.56 USD 6,083,946	199,082 -59.5%	30.56	USD 6,083,946
2023-11-06	2023-11-02	S Sale	Struthers Richard Scott President & CEO Executive Director	918 -0.7% 29.95 USD 27,494	918 -0.7%	29.95	USD 27,494
2023-11-03	2023-11-01	S Sale	Wilson Marc CFO Officer	10,000 -9.5% 28.75 USD 287,500	10,000 -9.5%	28.75	USD 287,500
2023-10-19	2023-10-17	S Sale	Krasner Alan Seth Chief Medical Officer Officer	7,000 -13.9% 30.00 USD 210,000	7,000 -13.9%	30.00	USD 210,000
2023-07-13	2023-07-13	S Sale	Struthers Richard Scott President & CEO Executive Director	14,157 -2.2% 20.35 USD 288,095	14,157 -2.2%	20.35	USD 288,095
2023-07-13	2023-07-12	S Sale	Struthers Richard Scott President & CEO Executive Director	11,459 -1.7% 20.17 USD 231,128	11,459 -1.7%	20.17	USD 231,128
2023-07-13	2023-07-11	S Sale	Struthers Richard Scott President & CEO Executive Director	24,384 -3.6% 20.14 USD 491,094	24,384 -3.6%	20.14	USD 491,094
2023-06-21	2023-06-20	S Sale	Wilson Marc CFO Officer	20,000 -17.4% 19.97 USD 399,400	20,000 -17.4%	19.97	USD 399,400
2023-06-21	2023-06-20	S Sale	Wilson Marc CFO Officer	10,922 -10.3% 19.96 USD 218,003	10,922 -10.3%	19.96	USD 218,003
2023-06-21	2023-06-16	S Sale	Struthers Richard Scott President & CEO Executive Director	50,000 -6.8% 20.81 USD 1,040,500	50,000 -6.8%	20.81	USD 1,040,500
2023-06-09	2023-06-08	B Purchase	Vivaldi Coelho Rogerio Non-Executive Director	5,000 +inf% 22.06 USD 110,300	5,000 +inf%	22.06	USD 110,300
2023-04-05	2023-04-05	S Sale	Pizzuti Dana Chief Development Officer Officer	8,212 -64.6% 16.15 USD 132,624	8,212 -64.6%	16.15	USD 132,624
2023-02-03	2023-02-01	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,126 -4.6% 19.59 USD 61,238	3,126 -4.6%	19.59	USD 61,238
2023-01-27	2023-01-25	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	8,336 -10.9% 21.07 USD 175,640	8,336 -10.9%	21.07	USD 175,640
2023-01-19	2023-01-17	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,126 -3.9% 18.00 USD 56,268	3,126 -3.9%	18.00	USD 56,268
2023-01-05	2023-01-03	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,126 -3.8% 18.35 USD 57,362	3,126 -3.8%	18.35	USD 57,362
2022-12-19	2022-12-15	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,126 -3.7% 16.00 USD 50,016	3,126 -3.7%	16.00	USD 50,016
2022-12-05	2022-12-01	PS Planned sale	Betz Stephen F. Chief Scientific Officer Officer	3,126 -3.5% 17.84 USD 55,768	3,126 -3.5%	17.84	USD 55,768

Crinetics Pharmaceuticals Inc (CRNX)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by